States Risk Losing Power to Regulate Pharmacy Drug Middlemen

Project Description

In the Press

Katie Gudiksen
Katie GudiksenSenior Health Policy Researcher

Lydia Wheeler
December 8, 2020

Senior Health Policy Researcher Katie Gudiksen was quoted in the 12/8/2020 Bloomberg Law article “States Risk Losing Power to Regulate Pharmacy Drug Middlemen”:

A challenge to an Arkansas law meant to protect independent pharmacies from abusive reimbursement practices of rate-setting pharmacy middlemen is testing the bounds of the Employee Retirement Income Security Act. A decision striking down Arkansas’s law could cripple state efforts to control the cost of prescription drugs and other health-care services. That could lead to a flood of litigation challenging dozens of similar laws in other states, health policy experts say.

“This is really the tip of the iceberg because states are trying to control drug costs in all kinds of different ways,” said Katherine Gudiksen, a senior health policy researcher at the Source on Healthcare Price and Competition, a project of the University of California Hastings College of Law.

Source Sightings